Loading clinical trials...
Loading clinical trials...
The purposes of this study are to: 1. Learn about the safety of CK-3773274 after a single dose and multiple doses in Chinese healthy adult subjects. 2. Learn how healthy subjects tolerate CK-3773274 ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Corxel Pharmaceuticals
Collaborators
NCT07367724 · Obstructive Hypertrophic Cardiomyopathy (oHCM)
NCT07232758 · Chinese Healthy Adult Subjects
NCT07021976 · Obstructive Hypertrophic Cardiomyopathy
NCT05569382 · Non-obstructive Hypertrophic Cardiomyopathy
NCT06635226 · Healthy Adult Subjects
Clinical Site
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions